CRON
Cronos Group IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$970.78M
P/E Ratio
—
EPS
$-0.02
Beta
1.21
52W High
$3.43
52W Low
$1.81
50-Day MA
$2.60
200-Day MA
$2.55
Dividend Yield
—
Profit Margin
-6.45%
Forward P/E
30.96
PEG Ratio
—
About Cronos Group Inc
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
Fundamentals
| Revenue (TTM) | $146.59M |
| Gross Profit (TTM) | $58.40M |
| EBITDA | $-3.35M |
| Operating Margin | -10.10% |
| Return on Equity | -0.26% |
| Return on Assets | -0.90% |
| Revenue/Share (TTM) | $0.38 |
| Book Value | $2.87 |
| Price-to-Book | 0.91 |
| Price-to-Sales (TTM) | 6.62 |
| EV/Revenue | 1.157 |
| EV/EBITDA | 1.90 |
| Quarterly Earnings Growth (YoY) | 238.80% |
| Quarterly Revenue Growth (YoY) | 47.00% |
| Shares Outstanding | $376.27M |
| Float | $197.58M |
| % Insiders | 48.17% |
| % Institutions | 16.54% |
Historical Volatility
HV 10-Day
49.94%
HV 20-Day
42.46%
HV 30-Day
44.15%
HV 60-Day
36.83%
HV Rank
60.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($2.30 target)
3
Buy1
HoldData last updated: 4/30/2026